| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 1.082 | 2.473 | 1.545 | 3.197 | 5.277 | 16.961 | 24.219 | 36.872 |
| Total Income - EUR | - | - | 1.082 | 2.473 | 1.545 | 3.197 | 5.277 | 16.962 | 24.221 | 37.458 |
| Total Expenses - EUR | - | - | 86 | 749 | 144 | 497 | 218 | 571 | 4.320 | 4.509 |
| Gross Profit/Loss - EUR | - | - | 996 | 1.725 | 1.401 | 2.700 | 5.059 | 16.391 | 19.901 | 32.949 |
| Net Profit/Loss - EUR | - | - | 963 | 1.650 | 1.355 | 2.606 | 4.901 | 15.907 | 17.195 | 27.782 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Rheumamed Center S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 1.128 | 2.648 | 3.952 | 6.506 | 11.307 | 25.266 | 42.743 | 31.634 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 0 | 12.374 | 19.226 | 30.503 |
| Cash | - | - | 1.128 | 2.648 | 3.952 | 6.506 | 11.307 | 12.893 | 23.517 | 1.130 |
| Shareholders Funds | - | - | 1.007 | 2.639 | 3.943 | 6.474 | 11.231 | 25.039 | 42.157 | 27.830 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 120 | 9 | 9 | 32 | 76 | 228 | 586 | 3.803 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Rheumamed Center S.r.l.